Growth Metrics

Cogent Biosciences (COGT) Total Liabilities (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Total Liabilities data on record, last reported at $18.1 million in Q3 2021.

  • For Q3 2021, Total Liabilities fell 23.79% year-over-year to $18.1 million; the TTM value through Sep 2021 reached $18.1 million, down 23.79%, while the annual FY2020 figure was $16.2 million, 8.0% down from the prior year.
  • Total Liabilities reached $18.1 million in Q3 2021 per COGT's latest filing, up from $15.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $32.0 million in Q1 2019 and bottomed at $10.8 million in Q1 2021.
  • Average Total Liabilities over 4 years is $21.7 million, with a median of $23.8 million recorded in 2020.
  • Peak YoY movement for Total Liabilities: crashed 60.02% in 2020, then surged 32.99% in 2021.
  • A 4-year view of Total Liabilities shows it stood at $25.7 million in 2018, then tumbled by 31.26% to $17.7 million in 2019, then fell by 8.0% to $16.2 million in 2020, then grew by 11.68% to $18.1 million in 2021.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $18.1 million in Q3 2021, $15.7 million in Q2 2021, and $10.8 million in Q1 2021.